Views: 0 Author: BioTeke Corporation Publish Time: 2025-10-22 Origin: Bioteke, China CDC
Mycoplasma pneumoniae (MP) is a unique, cell wall–deficient bacterium that causes respiratory tract infections, particularly atypical pneumonia, often referred to as “walking pneumonia.” Unlike typical bacterial infections, MP spreads slowly through respiratory droplets and primarily affects school-age children, teenagers, and young adults. Because it lacks a cell wall, it is resistant to many common antibiotics, such as penicillin and cephalosporins, making accurate diagnosis and targeted treatment essential.
MP infections are highly contagious and can spread through coughing, sneezing, or close personal contact. The incubation period typically ranges from 1 to 4 weeks. Outbreaks often occur in schools, dormitories, and military camps, where people live or work in close proximity.
One of the challenges in identifying MP infection is its gradual onset and similarity to viral respiratory infections, which often leads to underdiagnosis or misdiagnosis in early stages.
The symptoms of Mycoplasma pneumoniae infection are usually mild but can become serious in vulnerable groups. Common symptoms include:
Persistent dry cough
Fever and fatigue
Sore throat
Headache and body aches
Shortness of breath in severe cases
In some patients, MP infection can lead to complications such as bronchitis, otitis media, or even neurological and cardiac symptoms if left untreated.
Diagnosing Mycoplasma pneumoniae infection can be challenging due to its nonspecific clinical presentation. Traditional diagnostic methods include:
Culture Method – Growing the organism in specialized media, which is accurate but time-consuming (can take weeks).
Serological Tests – Detecting specific antibodies (IgM, IgG) in the blood, useful but may not identify acute infections.
Molecular Detection (PCR) – Amplifies bacterial DNA, offering high sensitivity and specificity.
Antigen Rapid Tests – Fast, convenient tools for clinical screening, detecting multiple pathogens from respiratory specimens within minutes.
With the rising incidence of mixed respiratory infections, combining multiple pathogen detections into one test is increasingly critical for early and accurate diagnosis.
Treatment for MP infection typically involves macrolide antibiotics such as azithromycin or clarithromycin. In adults, tetracyclines or fluoroquinolones may also be used. Supportive care — such as rest, hydration, and fever management — is important for recovery.
Because MP lacks a cell wall, β-lactam antibiotics are ineffective. Therefore, laboratory confirmation of MP infection is important to guide appropriate antibiotic therapy and avoid unnecessary or ineffective drug use.
To address the challenges of differential diagnosis in respiratory infections, Bioteke has developed the 6-in-1 Respiratory Antigen Rapid Test Kit, designed to simultaneously detect six common respiratory pathogens, including:
Influenza A virus
Influenza B virus
Respiratory Syncytial Virus (RSV)
Adenovirus (ADV)
SARS-CoV-2
Mycoplasma pneumoniae (MP)
This test uses immunochromatography and double-antibody sandwich technology, delivering results within 15 minutes using only a few drops of oropharyngeal swab samples.
Its advantages include:
Rapid and accurate detection for multiple pathogens
Simple operation, suitable for clinics, and healthcare professionals
CE certification ensuring international compliance and quality assurance
Convenient screening to support early isolation and targeted treatment
By combining Mycoplasma pneumoniae antigen detection with other major respiratory pathogens, the Bioteke 6-in-1 test provides clinicians with a powerful tool for differential diagnosis, especially during the high-incidence winter season.
Mycoplasma pneumoniae remains a significant cause of community-acquired pneumonia worldwide. Its subtle symptoms and resistance patterns make accurate and rapid diagnosis crucial for patient management and infection control.
With innovative tools like the Bioteke 6-in-1 Respiratory Antigen Rapid Test Kit, healthcare professionals can achieve faster, more comprehensive diagnostic insight — helping ensure timely treatment and better patient outcomes.